HBIO Harvard Bioscience: Earnings per share for the last 12 months

Harvard Bioscience Inc. (HBIO) - corporate logo

Is it worth investing in Harvard Bioscience (HBIO), a developer of precision systems for organ analysis and drug discovery? The EPS YoY TTM percentage trend provides the answer, with the 79.10 level serving as a critical benchmark. Risks are linked to trade wars and disruptions in optics supply chains. However, the deep integration of software into the scientific protocols of pharma behemoths creates a powerful barrier to entry for new players.

HBIO harvardbioscience.com: Net earnings per share for the last 12 months in the range 02/11/2024 - 11/14/2026

Financial and market metric breakdowns for Harvard Bioscience Inc. (HBIO)

- market price and analyst price targets:
Market Chart Harvard Bioscience Inc.|HBIO - Price Target Chart
- company stock capitalization data:
Market Capitalization Harvard Bioscience, Inc.|HBIO - Total Company Value
- book capitalization indicators:
Net Assets per Share Harvard Bioscience|HBIO - Company Net Assets|Market Cap to Book Value Multiple harvardbioscience.com|HBIO - Aggregate Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Harvard Bioscience|HBIO - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital harvardbioscience.com|HBIO - Company Debts|Debt to Book Value Harvard Bioscience|HBIO - Company Long-Term Debts|Short-Term Debt Harvard Bioscience|Immediate Liquidity Ratio harvardbioscience.com
- business earnings and investment ratios data:
HBIO - Net Income|Future Net Profit Harvard Bioscience|HBIO - Price to Earnings Ratio|Market Cap to Projected Earnings Harvard Bioscience, Inc.|HBIO - PEG Multiple|Business Value to Operating Income Before Depreciation Harvard Bioscience|HBIO - Operating profit EBITDA|Net earnings per share (EPS TTM) Harvard Bioscience|HBIO - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months harvardbioscience.com|HBIO - Net earnings per share growth this year|Net earnings per share growth forecast for next year Harvard Bioscience
- sales volume and revenue information:
HBIO - Revenue and Sales Volume|Projected Sales Volume harvardbioscience.com|HBIO - Price-to-Revenue Ratio|Forward Price to Sales Harvard Bioscience
Initial company analysis:Harvard Bioscience
Product sample of Harvard Bioscience, Inc.

Investors are verifying the resilience of Harvard Bioscience (HBIO) through profitability analysis, relying on the company's impeccable reputation as a benchmark in the biomedical instrumentation sector. The rolling annual EPS YoY trend reflects the percentage change in net income per share over the last twelve months, allowing for an assessment of the real capital growth rate independent of market volatility and short-term price fluctuations.

Competitor analysis for Harvard Bioscience

Net earnings per share for the last four quarters Intuitive Surgical, Inc. ISRG|Danaher Corporation Inc. (DHR) - Earnings per share for the last twelve months|BDX - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months STE|WST (westpharma.com) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Baxter (BAX)|Earnings per share for the last four quarters MASI|Earnings per share for the last twelve months Stevanato STVN|Net earnings per share (EPS TTM) Teleflex Corp TFX|MMSI: Net earnings per share for the last 12 months|NVST - Net earnings per share (EPS TTM)|ICU Medical Inc (ICUI) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Dentsply Sirona|LMAT (lemaitre.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months AtriCure Medical ATRC|Earnings per share for the last twelve months STAAR Surgical (STAA)|ChromaDex - Earnings per share for the last 12 months|ZimVie Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters ANGO (AngioDynamics Inc)|CERS - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Alpha Teknova Inc TKNO|monogramorthopedics.com (MGRM) - Earnings per share for the last twelve months|STSS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months InfuSystem Holdings, Inc.|UTMD (Utah Medical Products, Inc.) - Earnings per share for the last four quarters|Earnings per share for the last twelve months KORU Medical Systems, Inc. (KRMD)|Nyxoah S.A - Earnings per share for the last 12 months|Earnings per share for the last twelve months Microbot Medical Inc. MBOT|Net earnings per share for the trailing year Pro-Dex, Inc.|Zentek Corp - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Elutia ELUT|MLSS (Milestone Scientific Inc.) - Net earnings per share for the last 12 months|NXGL (NEXGEL, Inc.) - Earnings per share for the last twelve months|RVP (Retractable Tech) - Net earnings per share (EPS TTM)|Femasys (FEMY) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) MHUA|Net earnings per share for the last four quarters Predictive Oncology Corp|Earnings per share for the last twelve months Callan JMB Inc CJMB|Atrion Corporation Inc. (ATRI) - Net earnings per one share for the last twelve months|neurometrix.com - Net earnings per share (EPS TTM)